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These two papers marked the start of a series of descriptions of the epidemiology of 
onchocerciasis in west Africa. The work was led by John Anderson, an epidemiologist, and 
Harald Fuglsang, an ophthalmologist, who were based at the UK Medical Research Council’s 
Helminthiasis Research Unit, in Kumba, Cameroun in the 1970s. These papers provided the 
first truly systematic description of onchocerciasis, which was then and remains today a 
neglected tropical disease (NTD) affecting the poorest of the poor, and those ‘beyond the 
end of the road’. It is therefore a priority disease in the RSTMH’s strategy for 2017-2022 as 
well as being a priority for WHO in meeting the Sustainable Development Goals target of a 
90% reduction in the burden of NTDs by 2030. Both of these papers were highly influential 
in our understanding of the disease; the first paper determined the strength of association 
between various skin and eye lesions with onchocerciasis, while the second paper 
documented the differences in clinical manifestations between rain forest and savannah 
villages. 
Using standardized and detailed techniques Anderson and Fuglsang found that skin and eye 
disease were all significantly more prevalent in infected with onchocerciasis. The prevalence 
of consequent blindness reached over 4% in the rain forest and 14% in the savannah villages 
for those aged 40 years and over. In the second paper the authors found that while there 
were more nodules found in infected persons in the rain forest, eye lesions were generally 
more common and severe in the savannah – indeed in hyperendemic savannah villages the 
prevalance of blindness exceeded 30% for males over 40. The prevalence of skin lesions was 
about equal in the forest and the savannah villages but with different patterns of 
manifestation.          
These studies built on the work of previous investigators including Brian Duke, Roger 
Crosskey, Bill Kershaw, Rodolpho Robles and Rene Le Berre. Together, these studies 
provided much of the epidemiological background for the creation of the Onchocerciasis 
Control Programme (OCP), which was launched in 1974 by WHO in collaboration with the 
World Bank, the United Nations Development Programme (UNDP) and the Food and 
Agriculture Organization (FAO) [1].  
As the eye lesions and blindness were felt to be the most important clinical features of 
onchocerciasis the Programme was centred in the sahelian region of west Africa, where 
Anderson and Fuglsang had shown that the most severe forms of eye disease and blindness 
would be found. In the early years OCP operations were exclusively a vector control 
programme using aerial spraying. An appreciation that the blackfly vectors could fly large 
distances meant that the control area needed to be vast in order to prevent transmission of 
infection. It was well recognised from the outset that because adult Onchocerca volvulus 
worms were known to live for more than 10 years, the programme would have to be 
sustained for at least 12-15 years,  Eventually the OCP covered over 1 200 000 Km² to 
protect 30 million people in 11 countries and ran for 27 years. 
In 1987 Merck & Co., Inc made what was then an unprecedented donation to the OCP of as 
much ivermectin for as long as it was needed and this drug treatment was subsequently 
combined with the larviciding control measures, and eventually largely replaced them. By 
the time OCP closed in 2002 transmission of the disease had been virtually eliminated in the 
control areas. It had been one of the greatest public health achievements of the 20th 
century. OCP prevented an estimated 600 000 cases of blindness, 18 million children have 
been born in now-controlled areas and so spared from the risk of river blindness and 25 
million hectares of land have been made safe for cultivation and resettlement.    
Because ivermectin can be given as a single dose once or twice a year to entire populations, 
OCP had pioneered the use of Community Directed Treatment (CDT) with ivermectin and 
this formed the basis of the successor programme – the African Programme for 
Onchocerciasis Control (APOC) which ran from 1995 to 2015[2]. This CDT approach has 
subsequently been used by a number of disease control programmes and is now a well-
recognised public health approach. By the time APOC was launched there was more 
recognition of the importance of skin disease and its attendant psychosocial consequences. 
The work of Anderson and Fuglsang had shown that since these skin lesions were to be 
found as much in the forest as in savannah areas the programme needed to be expanded to 
cover the whole area where onchocerciasis is endemic. By the time APOC closed over 118 
million people had received ivermectin and over 25 million people were safe from the 
effects of river blindness [3]. The Onchocerciasis Elimination programme in the Americas 
had shown that elimination of infection was possible, and indeed in 13 of 15 foci in the New 
World transmission has now been interrupted. This has led the way to considering 
elimination of onchocerciasis in Africa, with several countries having achieved subnational 
elimination. APOC was succeeded in 2016 by the Expanded Special Project for the 
Elimination of NTDs (ESPEN) which is working to eliminate or control several NTDs as well as 
onchocerciasis [4]. 
The insights from these two papers are still central to our thinking about onchocerciasis and 
its control even today, 40 years later, when community treatment with ivermectin has 
eliminated transmission from almost all of Latin America and some parts of Africa [5, 6]. 
Several challenges to achieve elimination remain including the control and elimination of 
onchocerciasis in Loa co-endemic areas, accelerating the interruption of transmission 
through development of a safe and effective macrofilaricial drug, and the public health 
challenges of scaling up prevention programmes in hypoendemic areas with low risks of eye 
or skin disease but where transmission still continues.  
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